COVID-19 test

Qorvo Biotechnologies granted emergency use authorization, awarded $24.4M contract, to produce COVID-19 rapid test

Posted by Jason Parker | Apr 16, 2021

A new rapid antigen test that can identify whether a patient is COVID-19 positive in 20 minutes developed by Qorvo Biotechnologies has received emergency use authorization from the FDA, and the NIH awarded a $24.4 million contract to the company for its production.

Advanced Animal Diagnostics pivots to humans for COVID-19 test, with NCBiotech boost

Posted by WRAL News | Jun 16, 2020

North Carolina Biotechnology Center referred AAD for the Wells Fargo Innovation Incubator, or IN2. Launched in 2017 with $5 million from the Wells Fargo Foundation, the Channel Partner Awards is a competitive program open to IN2 channel partners — a network of more than 60 cleantech and sustainability-focused incubators, accelerators, and universities that refer promising startups to the program.